Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

References

• DomecgJPPrutskyGMullanRJAdverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysisJ Clin Endocrinol Metab201398124646465424092830
   PubMed Web of Science ®Google Scholar
• JohnsonNPMetformin use in women with polycystic ovary syndromeAnn Transl Med2014265610.3978/j.issn.2305-5839.2014.04.1525333031
   PubMedGoogle Scholar
• SirmansSMPateKAEpidemiology, diagnosis, and management of polycystic ovary syndromeClin Epidemiol2013611324379699
   PubMed Web of Science ®Google Scholar
• SetjiTLBrownAJPolycystic ovary syndrome: update on diagnosis and treatmentAm J Med20141271091291924859638
   PubMed Web of Science ®Google Scholar
• ZawadskiJKDunaifADiagnostic criteria for polycystic ovary syndromeGivensJHFMerrimanGThe Polycystic Ovary SyndromeCambridge, MABlackwell Scientific1992377384
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925
   Web of Science ®Google Scholar
• AzzizRCarminaEDewaillyDPositions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guidelineJ Clin Endocrinol Metab200691114237424516940456
   PubMed Web of Science ®Google Scholar
• SahaLKaurSSahaPKPharmacotherapy of polycystic ovary syndrome – an updateFundam Clin Pharmacol2012261546221210850
   PubMed Web of Science ®Google Scholar
• PeigneMDewaillyDLong term complications of polycystic ovary syndrome (PCOS)Ann Endocrinol (Paris)201475419419925156132
   PubMed Web of Science ®Google Scholar
• GlintborgDAltinokMLMummHHermannAPRavnPAndersenMBody composition is improved during 12 months’ treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndromeJ Clin Endocrinol Metab20149972584259124742124
   PubMed Web of Science ®Google Scholar
• ConwayGDewaillyDDiamanti-KandarakisEThe polycystic ovary syndrome: a position statement from the European society of endocrinologyEur J Endocrinol20141714P1P2924849517
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLVauhkonenLKoivunenRRuokonenAMartikainenHTapanainenJSMetformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab200388114815612519844
   PubMed Web of Science ®Google Scholar
• RautioKTapanainenJSRuokonenAMorin-PapunenLCEffects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndromeEur J Endocrinol2005152226927515745936
   PubMed Web of Science ®Google Scholar
• MitkovMPehlivanovBTerzievaDCombined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndromeEur J Obstet Gynecol Reprod Biol2005118220921315653205
   PubMed Web of Science ®Google Scholar
• SoaresGMVieiraCSde Paula MartinsWDos ReisRMde SaMFFerrianiRAMetabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndromeInt J Clin Pract200963116016918795969
   PubMed Web of Science ®Google Scholar
• LopezLMEdelmanAChenMOtternessCTrussellJHelmerhorstFMProgestin-only contraceptives: effects on weightCochrane Database Syst Rev20137CD00881510.1002/14651858.CD008815.pub323821307
   PubMedGoogle Scholar
• KaminskiPSzpotanska-SikorskaMWielgosMCardiovascular risk and the use of oral contraceptivesNeuro Endocrinol Lett201334758758924464000
   PubMed Web of Science ®Google Scholar
• KemmerenJMAlgraAGrobbeeDEThird generation oral contraceptives and risk of venous thrombosis: meta-analysisBMJ2001323730513113411463678
   PubMed Web of Science ®Google Scholar
• EssahPAArrowoodJACheangKIAdawadkarSSStovallDWNestlerJEEffect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndromeFertil Steril201196250150421733508
   PubMed Web of Science ®Google Scholar
• PanidisDGeorgopoulosNAPioukaAThe impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemiaGynecol Endocrinol201127858759220836726
   PubMed Web of Science ®Google Scholar
• BilgirOKebapcilarLTanerCThe effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS)Intern Med200948141193119919602786
   PubMed Web of Science ®Google Scholar
• ElterKImirGDurmusogluFClinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled studyHum Reprod20021771729173712093831
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLCVauhkonenIKoivunenRMRuokonenAMartikainenHKTapanainenJSEndocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab20008593161316810999803
   PubMed Web of Science ®Google Scholar
• HomburgRPolycystic ovary syndrome – from gynaecological curiosity to multisystem endocrinopathyHum Reprod199611129398671153
   PubMed Web of Science ®Google Scholar
• LinnekeJLJorgensenGKCsillagCMetformin for weight loss and control in patients with mood disorderJ Clin Psychiatry20147510e1140e114125373124
   PubMed Web of Science ®Google Scholar
• Bjorkhem-BergmanLAsplundABLindhJDMetformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysisJ Psychopharmacol201125329930520080925
   PubMed Web of Science ®Google Scholar
• Jensterle SeverMKocjanTPfeiferMKravosNAJanezAShort-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metforminEur J Endocrinol2014170345145924362411
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis-RuifrokAEKuchenbeckerWKHoekAMiddletonPNormanRJInsulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysisHum Reprod Update2009151576818927072
   PubMed Web of Science ®Google Scholar
• PauCTKeefeCDuranJWeltCKMetformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional studyJ Clin Endocrinol Metab20149951870187824606093
   PubMed Web of Science ®Google Scholar
• EhrmannDACavaghanMKImperialJSturisJRosenfieldRLPolonskyKSEffects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndromeJ Clin Endocrinol Metab19978225245309024248
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEKouliCTsianateliTBergieleATherapeutic effects of metformin on insulin resistant and hyperandrogenism in polycystic ovary syndromeEur J Endocrinol199813832692749539300
   PubMed Web of Science ®Google Scholar
• DomecgJPPrutskyGMullanRJLifestyle modification programs in polycystic ovary syndrome: systemic review and meta-analysisJ Clin Endocrinol Metab201398124655466324092832
   PubMed Web of Science ®Google Scholar
• NasriHRafieian-KopaeiMMetformin: current knowledgeJ Res Med Sci201419765866425364368
   PubMed Web of Science ®Google Scholar
• LalauJDLactic acidosis induced by metformin: incidence, management and preventionDrug Saf201033972774020701406
   PubMed Web of Science ®Google Scholar
• ScheenAJMetformin and lactic acidosisActa Clin Belg201166532933122145266
   PubMed Web of Science ®Google Scholar
• BrynhildsenJCombined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risksTher Adv Drug Saf20145520121325360241
   PubMedGoogle Scholar
• DragomanMVThe combined oral contraceptive pill-recent developments, risk and benefitsBest Pract Res Clin Obstet Gynaecol201428682583425028259
   PubMed Web of Science ®Google Scholar
• YildizBOApproach to the patient: contraception in women with polycystic ovary syndromeJ Clin Endocrinol Metab2015100379480225701301
   PubMed Web of Science ®Google Scholar